Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Analabs Resources Bhd's average EBITDA Per Share Growth Rate was 27.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 20.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 16.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 14.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Analabs Resources Bhd was 53.20% per year. The lowest was -17.40% per year. And the median was 10.55% per year.
Analabs Resources Bhd (XKLS:7083) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Analabs Resources Bhd 5-Year EBITDA Growth Rate Related Terms
XKLS:7083 vs LIN, SHW, ECL: 5-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Analabs Resources Bhd's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Analabs Resources Bhd 5-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Analabs Resources Bhd's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Analabs Resources Bhd's 5-Year EBITDA Growth Rate falls into.
Analabs Resources Bhd 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of 16.40% mean?
Analabs Resources Bhd (XKLS:7083) has a 5-Year EBITDA Growth Rate of 16.40% as of Apr. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Analabs Resources Bhd and its competitors.
Is Analabs Resources Bhd's 5-Year EBITDA Growth Rate too high?
Analabs Resources Bhd's current 5-Year EBITDA Growth Rate is 16.40%. Overall, Analabs Resources Bhd has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Analabs Resources Bhd's 5-Year EBITDA Growth Rate compare to LIN and SHW?
Analabs Resources Bhd's 5-Year EBITDA Growth Rate of 16.40% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Chemicals company?
A good 5-Year EBITDA Growth Rate depends on the Chemicals industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Analabs Resources Bhd and its competitors. Analabs Resources Bhd's current 5-Year EBITDA Growth Rate is 16.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Analabs Resources Bhd stock overvalued right now?
Based on GuruFocus' analysis, Analabs Resources Bhd (XKLS:7083) is currently considered Modestly Overvalued. The stock's GF Value™ is RM1.53, compared to a current price of RM1.75 — trading 14.4% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 16.40%. Analabs Resources Bhd's overall GF Score™ is 68/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Analabs Resources Bhd (XKLS:7083), the current 5-Year EBITDA Growth Rate is 16.40% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Analabs Resources Bhd (XKLS:7083) Overvalued in 2026?
Based on GuruFocus' analysis, Analabs Resources Bhd stock appears to be overvalued.
The current stock price of RM1.75 is trading 14.4% above its estimated GF Value™ of RM1.53.
GuruFocus considers Analabs Resources Bhd to be Modestly Overvalued.
Key valuation signals for XKLS:7083:
5-Year EBITDA Growth Rate: 16.40%
GF Value™: RM1.53 vs. price of RM1.75 (14.4% above fair value)
No single metric tells the full story. See the XKLS:7083 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Analabs Resources Bhd is a Malaysia-based company engaged in the businesses of investment holding and the provision of management services. It has five business segments, which include: Manufacturing, formulation, and sale of resin, chemicals, and building materials; Recovery and sale of recycled products; Contract work, pipe laying, and rehabilitation; Culture and sale of prawns; Investment holding and property letting, and asset and portfolio management. The company earns the majority of its revenue from the manufacturing, formulation, and sale of resin, chemicals, and building materials. Geographically, the company derives its maximum revenue from Malaysia and the rest from Singapore.
68GF Score
Get the complete analysis for XKLS:7083
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7083 has been successfully added to your 
